Afatinib/gefitinibAcquired resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32627-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[1] Afatinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 28 - 28
[2] GefitinibAcquired resistance: case report
Reactions Weekly, 2019, 1756 (1) : 161 - 161
[3] GefitinibAcquired resistance: case report
Reactions Weekly, 2022, 1904 (1) : 236 - 236
[4] Afatinib/erlotinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1696 (1) : 18 - 18
[5] GefitinibAcquired resistance: case report
Reactions Weekly, 2018, 1696 (1) : 171 - 171
[6] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1705 (1) : 15 - 15
[7] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2020, 1833 (1) : 185 - 185
[8] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2021, 1866 (1) : 187 - 187
[9] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2020, 1824 (1) : 139 - 139
[10] GefitinibAcquired drug resistance: case report
Reactions Weekly, 2018, 1723 (1) : 155 - 155

← 1 2 3 4 5 →